NCT00427856View on ClinicalTrials.gov

Safety and Efficacy of Single Agent Obatoclax Mesylate (GX15-070MS) Followed by a Combination With Rituximab for Previously-untreated Follicular Lymphoma (FL)

PHASE2CompletedINTERVENTIONAL
Enrollment

7

Participants

Timeline

Start Date

March 31, 2007

Primary Completion Date

February 28, 2009

Study Completion Date

July 31, 2009

Conditions
Lymphoma, Follicular
Interventions
DRUG

Obatoclax mesylate

Obatoclax mesylate 40mg, and 60mg

DRUG

Rituximab

Rituximab

Trial Locations (1)

07601

The Cancer Center at Hackensack University Medical Center, Hackensack

Sponsors

Lead Sponsor

Gemin X
All Listed Sponsors
lead

Gemin X

INDUSTRY

NCT00427856 - Safety and Efficacy of Single Agent Obatoclax Mesylate (GX15-070MS) Followed by a Combination With Rituximab for Previously-untreated Follicular Lymphoma (FL) | Biotech Hunter | Biotech Hunter